Exenatide's effects on the liver's circadian clock depend on dosing time — administration at the start of the active period (morning equivalent) prevented clock disruption from irregular eating, working through central nervous system GLP-1 receptors.
Timing-dependent clock effectsExenatide given at the start of the active period protected the hepatic clock; the same drug at rest onset worsened disruption
What the researchers found
Exenatide time-dependently modulates the hepatic circadian clock through CNS GLP-1 receptors. Morning-equivalent dosing (ZT12) counteracted clock disruption from irregular eating; evening-equivalent dosing (ZT0) worsened it. CNS GLP-1 receptor knockdown attenuated these effects.
Why it matters
Circadian disruption is increasingly linked to metabolic disease. This provides a scientific rationale for morning dosing of GLP-1 agonists — and suggests an additional mechanism (clock restoration) beyond the known effects on appetite and blood sugar.
The numbers in context
Time-dependent effects on hepatic clock genes observed. CNS-specific GLP1R knockdown eliminated the liver clock effects.
How the study worked
Male C57BL/6J and CNS-specific GLP-1 receptor knockdown (GLP1RKD) mice under 12h/12h light/dark cycle. Time-restricted feeding to either light (L-TRF) or dark (D-TRF) period. Exenatide administered 4-5 times daily at ZT12 or ZT0. Hepatic clock gene expression rhythms analyzed by mRNA expression.
Who was studied
Male C57BL/6J and GLP1R knockdown mice
What this study cannot tell us
Mouse study with controlled feeding schedules that don't mirror human eating patterns. Only clock gene mRNA was measured, not long-term metabolic outcomes. The translation to once-weekly GLP-1 agonists (semaglutide, tirzepatide) versus daily exenatide isn't clear.
How to read the evidence
Preliminary evidence from a well-designed animal study using both wild-type and CNS-specific GLP-1 receptor knockdown mice. Mechanistically rigorous but without human clinical validation.
When this study was published
Published in 2024; contributes to the emerging field of GLP-1 chrono-pharmacology.
The bigger picture
Chrono-pharmacology — optimizing drug timing for maximum benefit — is gaining traction across medicine. This study provides compelling evidence that GLP-1 agonist timing isn't just about convenience but can fundamentally alter their metabolic impact through circadian biology.
Questions still open
- Does the timing principle apply to once-weekly GLP-1 agonists like semaglutide and tirzepatide?
- Could morning GLP-1 agonist dosing improve metabolic outcomes in shift workers with disrupted circadian rhythms?
- What other peripheral tissue clocks does exenatide influence through central GLP-1 receptors?
Common questions
Does it matter what time of day I take my GLP-1 medication?
What does the liver's circadian clock have to do with diabetes?
Read the original research
Exenatide administration time-dependently affects the hepatic circadian clock through glucagon-like peptide-1 receptors in the central nervous system.
Biochemical pharmacology, 230(Pt 1), 116567
Citation
Xu, Pingping; Morishige, Jun-Ichi; Jing, Zheng; Nagata, Naoto; Shi, Yifan; Iba, Tomohiro; Daikoku, Takiko; Ono, Masanori; Maida, Yoshiko; Fujiwara, Tomoko; Fujiwara, Hiroshi; Ando, Hitoshi. (2024). Exenatide administration time-dependently affects the hepatic circadian clock through glucagon-like peptide-1 receptors in the central nervous system.. Biochemical pharmacology, 230(Pt 1), 116567. https://doi.org/10.1016/j.bcp.2024.116567